Today we have even more bad news in two separate studies about the diabetes drug Avandia. With the bad news we get all the time about diabetes you might wonder why I report more negative stuff.
It’s because we have much better alternatives.
It was easier for me to find the trail at nearly 11,000 feet in the Indian Peaks Wilderness yesterday than to find the theater where I saw Michael Moore’s documentary Sicko. That’s because I hike a lot and this was the first time I have ever gone to a movie theater since 2004, when I moved to Boulder, Colorado. This isn’t a big town – barely 100,000 people, but I just didn’t know where the theater is and had to drive all around to find it.
For years I’ve recommended to the meter manufacturers that they include activity recognition in their testing options. Now some companies are beginning to do just that.
The new diabetes drug, Byetta, can help us control our blood glucose and lose weight. In animal experiments it stimulates the birth of new beta cells, make more beta cells develop, and increase the mass of beta cells.
The third day of the American Diabetes Association’s convention in the so-called Windy City blew me away in more ways than one.
The high point of the second day of the American Diabetes Association convention in Chicago has been not something I learned about diabetes in general. It is instead what I learned about myself.